Bright Minds Biosciences, Inc. (DRUG.CX)

97.11 -4.22 (-4.16%) CAD  |  CNSX  |  Mar 27, 16:00
More

Bright Minds Biosciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for DRUG.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Fennec Pharmaceuticals, Inc. Upgrade
Green Thumb Industries, Inc. Upgrade
Lowell Farms, Inc. --
Wesana Health Holdings, Inc. --
Sharp Therapeutics Corp. --